CN107982372A - 一种治疗心血管疾病的药物及其制作方法 - Google Patents
一种治疗心血管疾病的药物及其制作方法 Download PDFInfo
- Publication number
- CN107982372A CN107982372A CN201610943712.6A CN201610943712A CN107982372A CN 107982372 A CN107982372 A CN 107982372A CN 201610943712 A CN201610943712 A CN 201610943712A CN 107982372 A CN107982372 A CN 107982372A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- angiocardiopathy
- medicinal extract
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 13
- 244000252337 Epipremnum pinnatum Species 0.000 claims abstract description 11
- 235000003365 Ilex pubescens Nutrition 0.000 claims abstract description 11
- 241001100932 Ilex pubescens Species 0.000 claims abstract description 11
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 11
- 241001646828 Platostoma chinense Species 0.000 claims abstract description 11
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 11
- 241001148782 Davallia Species 0.000 claims abstract description 10
- 244000241872 Lycium chinense Species 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 244000294611 Punica granatum Species 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 2
- 235000008434 ginseng Nutrition 0.000 claims 2
- 239000008188 pellet Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 241000219991 Lythraceae Species 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 4
- 208000034189 Sclerosis Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗心血管疾病的药物及其制备方法,本发明所述药物主要由丹参、三七、刺五加、毛冬青、石柑子、地骨皮、石榴叶、骨碎补和仙人草制作而成。处方中各原料具有很好的协同作用,制成的药物可用于治疗心血管疾病;疗效显著,治疗周期短,安全无副作用。
Description
技术领域
本发明涉及一种治疗心血管疾病的药物及其制作方法,属于药品技术的领域。
背景技术
心血管疾病,又称为循环系统疾病,是一系列涉及循环系统的疾病,循环系统指人体内运送血液的器官和组织,主要包括心脏、血管(动脉、静脉、微血管),可以细分为急性和慢性,一般都是与动脉硬化有关。这些疾病都有着相似的病因、病发过程及治疗方法。
血管疾病,又称为循环系统疾病,是一系列涉及循环系统的疾病,循环系统指人体内运送血液的器官和组织,主要包括心脏、血管(动脉、静脉、微血管),可以细分为急性和慢性,一般都是与动脉硬化有关。这些疾病都有着相似的病因、病发过程及治疗方法。
针对上述疾病,虽然目前用于治疗心血管疾病的药物有很多,但是大多数药物只是针对药效缓慢,治疗周期长。
发明内容
本发明的目的在于,提供一种治疗心血管疾病的药物及其制作方法。所述药物可治疗心血管疾病;疗效显著,治疗周期短,安全无副作用。
为解决上述技术问题,本发明采用以下技术方案实现:
一种治疗心血管疾病的药物,按重量份计算,主要由丹参20-40份、三七5-35份、刺五加10-30份、毛冬青10-30份、石柑子10-30份、地骨皮20-40份、石榴叶20-40份、骨碎补20-40份和仙人草20-40份制作而成。
前述的治疗心血管疾病的药物,按重量份计算,主要由丹参25-35份、三七15-25份、刺五加15-25份、毛冬青15-25份、石柑子15-25份、地骨皮25-35份、石榴叶25-35份、骨碎补25-35份和仙人草25-35份制作而成。
前述的治疗心血管疾病的药物,按重量份计算,主要由丹参30份、三七20份、刺五加20份、毛冬青20份、石柑子20份、地骨皮30份、石榴叶30份、骨碎补30份和仙人草30份制作而成。
一种前述的治疗心血管疾病的药物的制作方法,取上述药物,可以加辅料,也可以不加辅料,制成口服制剂。
前述的治疗心血管疾病的药物的制作方法,所述口服制剂为颗粒剂、胶囊剂、片剂、丸剂、散剂或霜剂。
前述的治疗心血管疾病的药物的制作方法,所述颗粒剂这样制作:取上述药物,加10倍量水煎煮3次,每次1.5h,过滤,合并煎煮液,浓缩成50-60℃时相对密度为1.15-1.20的浸膏,浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒,干燥,即得。
前述的治疗心血管疾病的药物的制作方法,所述胶囊剂的制作方法为:取上述药物,用6倍量70%的乙醇回流提取2次,每次1小时,提取液过滤,滤液回收乙醇并浓缩成50-60℃时相对密度为1.20-1.25的浸膏,另取浸膏量30%的淀粉和0.7%的硬脂酸镁与浸膏混匀,用60%的乙醇制粒,干燥,粉碎,填充胶囊,即得。
前述的治疗心血管疾病的药物的制作方法,所述片剂的制作方法为:取上述药物,加10倍量水煎煮3次,每次1.5h,过滤,合并煎煮液,浓缩成50-60℃时相对密度为1.15-1.20的浸膏,浸膏与上述混合粉及浸膏量20%的淀粉混匀,压片,包薄膜衣,即得。
与现有技术相比,本发明所述药物主要由丹参、三七、刺五加、毛冬青、石柑子、地骨皮、石榴叶、骨碎补和仙人草制作而成。处方中各原料具有很好的协同作用,制成的药物可用于治疗心血管疾病;疗效显著,治疗周期短,安全无副作用。
具体实施方式:
实施例1.
配方:丹参30kg、三七20kg、刺五加20kg、毛冬青20kg、石柑子20kg、地骨皮30kg、石榴叶30kg、骨碎补30kg和仙人草30kg。
工艺:取上述药物,加10倍量水煎煮3次,每次1.5h,过滤,合并煎煮液,浓缩成50-60℃时相对密度为1.15-1.20的浸膏,浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒,干燥,即得。
规格:5g/袋。
用法用量:每次5-10g,每日2-3次。
实施例2.
配方:丹参30kg、三七20kg、刺五加20kg、毛冬青20kg、石柑子20kg、地骨皮30kg、石榴叶30kg、骨碎补30kg和仙人草30kg。
工艺:取上述药物,用6倍量70%的乙醇回流提取2次,每次1小时,提取液过滤,滤液回收乙醇并浓缩成50-60℃时相对密度为1.20-1.25的浸膏,另取浸膏量30%的淀粉和0.7%的硬脂酸镁与浸膏混匀,用60%的乙醇制粒,干燥,粉碎,填充胶囊,即得胶囊剂。
规格:0.3g/粒。
用法用量:每次5-10g,每日2-3次。
实施例3.
配方:丹参30kg、三七20kg、刺五加20kg、毛冬青20kg、石柑子20kg、地骨皮30kg、石榴叶30kg、骨碎补30kg和仙人草30kg。
工艺:取上述药物,加10倍量水煎煮3次,每次1.5h,过滤,合并煎煮液,浓缩成50-60℃时相对密度为1.15-1.20的浸膏,浸膏与上述混合粉及浸膏量20%的淀粉混匀,压片,包薄膜衣,即得片剂。
规格:0.3g/片。
用法用量:每次5-10g,每日2-3次。
Claims (8)
1.一种治疗心血管疾病的药物,其特征在于:按重量份计算,主要由丹参20-40份、三七5-35份、刺五加10-30份、毛冬青10-30份、石柑子10-30份、地骨皮20-40份、石榴叶20-40份、骨碎补20-40份和仙人草20-40份制作而成。
2.如权利要求1所述的治疗心血管疾病的药物,其特征在于:按重量份计算,主要由丹参25-35份、三七15-25份、刺五加15-25份、毛冬青15-25份、石柑子15-25份、地骨皮25-35份、石榴叶25-35份、骨碎补25-35份和仙人草25-35份制作而成。
3.如权利要求2所述的治疗心血管疾病的药物,其特征在于:按重量份计算,主要由丹参30份、三七20份、刺五加20份、毛冬青20份、石柑子20份、地骨皮30份、石榴叶30份、骨碎补30份和仙人草30份制作而成。
4.一种如权利要求1-3中任一项所述的治疗心血管疾病的药物的制作方法,其特征在于:取上述药物,可以加辅料,也可以不加辅料,制成口服制剂。
5.如权利要求4所述的治疗心血管疾病的药物的制作方法,其特征在于:所述口服制剂为颗粒剂、胶囊剂、片剂、丸剂、散剂或霜剂。
6.如权利要求5所述的治疗心血管疾病的药物的制作方法,其特征在于:所述颗粒剂这样制作:取上述药物,加10倍量水煎煮3次,每次1.5h,过滤,合并煎煮液,浓缩成50-60℃时相对密度为1.15-1.20的浸膏,浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒,干燥,即得。
7.如权利要求5所述的治疗心血管疾病的药物的制作方法,其特征在于:所述胶囊剂的制作方法为:取上述药物,用6倍量70%的乙醇回流提取2次,每次1小时,提取液过滤,滤液回收乙醇并浓缩成50-60℃时相对密度为1.20-1.25的浸膏,另取浸膏量30%的淀粉和0.7%的硬脂酸镁与浸膏混匀,用60%的乙醇制粒,干燥,粉碎,填充胶囊,即得。
8.如权利要求5所述的治疗心血管疾病的药物的制作方法,其特征在于:所述片剂的制作方法为:取上述药物,加10倍量水煎煮3次,每次1.5h,过滤,合并煎煮液,浓缩成50-60℃时相对密度为1.15-1.20的浸膏,浸膏与上述混合粉及浸膏量20%的淀粉混匀,压片,包薄膜衣,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610943712.6A CN107982372A (zh) | 2016-10-26 | 2016-10-26 | 一种治疗心血管疾病的药物及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610943712.6A CN107982372A (zh) | 2016-10-26 | 2016-10-26 | 一种治疗心血管疾病的药物及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107982372A true CN107982372A (zh) | 2018-05-04 |
Family
ID=62028652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610943712.6A Pending CN107982372A (zh) | 2016-10-26 | 2016-10-26 | 一种治疗心血管疾病的药物及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107982372A (zh) |
-
2016
- 2016-10-26 CN CN201610943712.6A patent/CN107982372A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1994451B (zh) | 治疗抑郁症的中药组合物及其制备方法和其应用 | |
CN104958427A (zh) | 用于治疗气血虚弱型痛经的中药 | |
CN100998767A (zh) | 一种治疗骨折的中药及其制备方法 | |
CN105250495A (zh) | 一种保肝、护肝的中药组合物 | |
CN105311492A (zh) | 一种用于冠状动脉粥样硬化性心脏病的药物 | |
CN108096318A (zh) | 治疗心脑血管疾病的药物组合物及其制备方法和用途 | |
CN107982372A (zh) | 一种治疗心血管疾病的药物及其制作方法 | |
CN103083488B (zh) | 一种用于治疗骨病的中药组合物及其制剂 | |
CN105687522A (zh) | 一种具有祛黄褐斑功能的药物组合物及其制备方法 | |
CN109512871A (zh) | 一种治疗心血管疾病的药物及其制作方法 | |
CN105748553A (zh) | 一种活血消肿解毒的中药组合物及其制备方法 | |
CN107961316A (zh) | 一种治疗糖尿病的胶囊制剂及其制作方法 | |
CN103845504A (zh) | 一种治疗足跟痛的龟鹿中药饮片 | |
CN106581165A (zh) | 一种治疗高血压的药物及其制作方法 | |
CN107854612A (zh) | 一种治疗便秘的药物及其制备方法 | |
CN108066496A (zh) | 一种护肝中药保健食品 | |
CN107982374A (zh) | 一种治疗糖尿病的药物及其制作方法 | |
CN107961315A (zh) | 一种治疗糖尿病的药物及其制作方法 | |
CN109512938A (zh) | 一种治疗糖尿病的药物及其制作方法 | |
CN105878635A (zh) | 一种舒筋活血的中药组合物及其制备方法 | |
CN107970283A (zh) | 一种治疗荨麻疹的药物及其制作方法 | |
CN104491602A (zh) | 一种治疗慢性心衰、早搏、心律失常的中药及其制备方法 | |
CN105748768A (zh) | 一种风湿镇痛中药组合物及制备方法 | |
CN111067996A (zh) | 用于制备缓解疼痛药物的组合物及药物制备方法 | |
CN107970287A (zh) | 一种治疗骨质疏松的药物及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180504 |
|
WD01 | Invention patent application deemed withdrawn after publication |